Place and date of birth
Varaždin (Croatia), 1969
Education
- Faculty of Science, University of Zagreb (1987-1992)
- Postgraduate study (Biology), Faculty of Science, University of Zagreb (1993-2000)
Work Experience
- University of Zagreb, Faculty of Science, Department of Biology, Division of Zoology (1992-1997)
- Institute for Medical Research and Occupational Health, Mutagenesis Unit (since 1997)
Fields of interest
genetic Toxicology; cytogenetics; biomonitoring; studying the effects of physical and chemical mutagens in vitro and in vivo; science editing
Select Publications
- KOPJAR N, GARAJ-VRHOVAC V, KAŠUBA V, ROZGAJ R, RAMIĆ S, PAVLICA V, ŽELJEŽIĆ D. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: A multi-biomarker approach. International Journal of Hygiene and Environmental Health 2009;212(4):414-431.
- KOPJAR N, KAŠUBA V, ROZGAJ R, ŽELJEŽIĆ D, MILIĆ M, RAMIĆ S, PAVLICA V, MILKOVIĆ-KRAUS S. The genotoxic risk in health care workers occupationally exposed to cytotoxic drugs – A comprehensive evaluation by the SCE assay. Journal of Environmental Science and Health – Part A Toxic/Hazardous Substances and Environmental Engineering 2009;44(5):462-479.
- KOPJAR N, MILAS I, GARAJ-VRHOVAC V, GAMULIN M. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients. Human and Experimental Toxicology, 2007;26(5):391-399.
- KOPJAR N, ŽELJEŽIĆ D, LUCIĆ VRDOLJAK A, RADIĆ B, RAMIĆ S, MILIĆ M, GAMULIN M, PAVLICA V, FUČIĆ A. Irinotecan toxicity to human blood cells in vitro: Relationship between various biomarkers. Basic & Clinical Pharmacology & Toxicology 2007;100(6):403-413.
- KOPJAR N, GARAJ-VRHOVAC, V, MILAS I. Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay. Teratogenesis Carcinogenesis Mutagenesis 2002;22(1):13-30.
- KOPJAR N, GARAJ-VRHOVAC, V. Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis 2001; 16(1):71-78.